Search Results 801-810 of 16383 for monoclonal antibody

1. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

   Other monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, antibody-like drugs, cytokines, cell therapies, or radioimmunoconjugates: 4 weeks.

2. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

3. Overview - Department of Immunology - Mayo Clinic Research

   Chronic inflammation; Infections; Tissue transplantation. Two institutional core research resources, the Antibody Hybridoma Core and the Immune Monitoring Core, ...

4. Mayo Clinic Q and A: Different types of COVID-19 tests

   Antibody testing, also called serology testing, determines if someone has been infected in the past. Antibodies are produced by a person's immune system, and ...

5. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - History of splenectomy within the 3 months prior to screening. - Received rituximab or other anti-CD20 monoclonal antibody <3 months prior to screening ...

6. A Study to Evaluate Positive SARS-CoV-2 Antibodies in Subjects with Bipolar Disorder - Mayo Clinic

   The purpose of this study is to evaluate the clinical and neurocognitive correlates of COVID-19 in patients with bipolar disorder (BD). Participation ...

7. Brain Tumor Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as ... Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan.

8. A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) - Mayo Clinic

   A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease ...

9. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

   Received an anti-CLL monoclonal antibody within 8 weeks prior to the first dose of study drug. Received any anti-cancer or investigational therapy within 14 ...

10. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody therapy; Palliative radiation therapy is permitted if clinically indicated and not indicative of progressive disease. Participating Mayo ...